Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3315-3319

  Zhang, Shengle ^a   Graeber, Linda A ^a   Helling, Friedhelm ^a,b   Ragupathi, Govindaswami ^a   Adluri, Sucharita ^a   Lloyd, Kenneth O ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Active Biotherapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; KEYHOLE LIMPET HEMOCYANIN; MUCIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECRETORY CELL; SOLID TUMOR;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CYTOTOXICITY, IMMUNOLOGIC; IMMUNOGLOBULIN G; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUCINS; NEOPLASM METASTASIS; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC; VACCINES;

EID: 0029951136     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arklie, J., Taylor-Papadimitriou, J., Bodmer, W., Egan, M., and Millis, R Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J. Cancer, 28: 23-29, 1981
2. Kotera, Y , Fontenot, J. D., Pecher, G , Metzgar, R. S , and Finn, O J. Human immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res., 54 2856-2860, 1994
3. Devine, P L , Layton, G. T., Clark, B. A , Birrell, G. W., Ward, B. G , Xing, P. X., and McKenzie, F. C. Production of MUC1 and MUC2 mucins by human tumor cell lines. Biochem. Biophys. Res. Commun., 178: 593-599, 1991.
4. Hollingsworth, M. A., Strawhecker, J M., Caffrey T. C., and Mack, D R. Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines. Int. J. Cancer, 57: 198-203, 1994
5. Hareuveni, M., Gautier, C., Kieny, M-P., Wreschner, D , Chambon, P., and Lathe, R. Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Proc. Natl. Acad Sci. USA, 87: 9498-9502, 1990.
6. Gendler, S. J., Spicer, A P., Lalani, E-N, Duhig, T , Peat, N., Burchell, J , Pemberton, L., Boshell, M., and Taylor-Papadimitriou, J. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis., 144 S42-S47, 1991.
7. Burchell, J , Taylor-Papadimitriou, J , Boshell, M , Gendler, S , and Duhig, T. A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int. J. Cancer, 44: 691-696, 1989.
8. Fontenot, J D., Tjandra, N , Bu, D., Ho, C., Montelaro, R. C., and Finn, O. J. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res., 53: 5386-5394, 1993.
9. Perez, L., Hayes, D. F., Maimonis, P , Abe, M., O'Hara, C., and Kufe, D. W. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen Cancer Res., 52: 2563-2568, 1992
10. Ding, L., Lalani, E-N., Reddish, M , Koganty, R., Wong, T , Samuel, J., Yacyshyn, M B., Meikle, A., Fung, P. Y S., Taylor-Papadimitriou, J , and Longenecker, B. M. Immunogenecity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene Cancer Immunol Immunother., 36: 9-17, 1993.
11. Taylor-Papadimitriou, J., Peterson, J. A , Arklie, J., Burchell, J., Ceriani, R. L., and Bodmer, W. F. Monoclonal antibodies to epithelium specific components of the milk fat globule membrane: production and reactions with cells in culture. Int. J. Cancer, 28: 17-21, 1981.
12. Miller, F. R., Miller, B. E , and Heppner, G. H. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor. heterogeneity in phenotypic stability Invasion Metastasis, 3: 22-31, 1983.
13. Lalani, E-N , Berdichevsky, F , Boshell, M., Shearer, M., Wilson, D., Stauss, H , Gendler, S. J., and Taylor-Papadimitriou, J Expression of the gene coding for a human mucin in mouse mammary tumor cells can affect their tumorigenicity J. Biol Chem., 266 15420-15426, 1991.
14. Soule, H. D., Vazquez, J , Long, A , Albert, S , and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma J Natl. Cancer Inst., 51: 1409-1416, 1973
15. Kensil, C. R , Patel, U., Lennick, M , and Marciani, D Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immunol., 146: 431-437, 1991.
16. Maloy, W. L., Coligan, J. E , and Paterson, Y. Production of antipeptide antisera. In: J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E M Shevach, and W. Strober (eds ), Current Protocols in Immunology, pp 9 4 1-9 4.11. New York: John Wiley & Sons, Inc , 1994
17. Carlesson, J , Drevin, H., and Axen, R Protein thiolation and reversible protein-protein conjugation N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J., 173: 727-737, 1978
18. Livingston, P O., Ritter, G , and Calves, M. J Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2, and GD3 in the mouse. Cancer Immunol. Immunother , 29: 179-184, 1989.
19. Zhang, S., Helling, F., Lloyd, K. O , and Livingston, P. O Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides. Cancer Immunol. Immunother., 40: 88-94, 1995.
20. James, S. P. Measurement of proliferative responses of cultured lymphocytes. In: J. E. Coligan, A. M Kruisbeek, D. H. Margulies, E. M Shevach, and W Strober (eds ), Current Protocols in Immunology, pp. 7.10 1-7.10.10. New York: John Wiley & Sons, Inc , 1994
21. Luo, Y , and Dorf, M. E. Delayed-type hypersensitivity. In: J. E. Coligan, A M. Kruisbeek, D. H. Margultes, E. M Shevach, and W, Strober (eds.), Current Protocols in Immunology, pp 4 5.1-4.5.5 New York John Wiley & Sons, Inc., 1994.
22. Wunderlich, J., and Shearer, G. Induction and measurement of cytotoxic T lymphocyte activity. In: J. E Coligan, A. M. Kruisbeek, D. H. Margulies, E M. Shevach, and W. Strober (eds.), Current Protocols in Immunology, pp. 3.11.1-3.11.15. New York: John Wiley & Sons, Inc., 1994.
23. Dohi, T , Nores, G. A., Oguchi, H., Inufusa, H., and Hakomori, S GD3 lactone as an immunogen associated with melanoma: effect of immunization with GM3 lactone on melanoma growth in vivo. In: H. F. Oettgen (eds.), Gangliosides and Cancer, pp. 275-281 Weinheim, Germany: VCH Verlagsgesellschaft, 1988.
24. Rughetti, A , Turchi, V , Ghetti, C. A., Scambia, G., Panici, P B., Roncucci, G , Mancuso, S , Frati, L., and Nuti, M Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res., 53: 2457-2459, 1993.
25. Jerome, K R., Barnd, D L , Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J., McKenzie, I F. C., Bast, R. C., Jr., and Finn, O J. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res., 51: 2908-2916, 1991
26. Ioannides, C. G , Fisk, B., Jerome, K R., Irimura, T. Wharton, J. T , and Finn, O. J. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J. Immunol., 151: 3693-3703, 1993.
27. Newmann, M. J., Wu, J-Y , Gardner B. H., Munroe, K J., Leombruno, D., Recchia, J., Kensil, C. R , and Coughlin, R. T. A sponin adjuvant induction of ovalbumen-specific CD8+ cytotoxic T-lymphocyte responses. J. Immunol., 148: 2357-2360, 1992.
28. Apostolopoulos, V , Xing, P-X., and McKenzie, F. C Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens. Cancer Res., 54 5186-5193, 1994.
29. Bu, D., Domenech, N., Lewis, J , Taylor-Papadimitnou, J , and Finn, O. J Recombinant vaccine mucin vector, in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition. J. Immunol , 14: 127-135, 1993
30. Finn, O. J. Immunity to epithelial tumors and mucin-based vaccine design. Proc. Am. Assoc. Cancer Res., 36: 675, 1995
31. Engelhard, V. H Structure of peptides associated with class I and class II MHC molecules. Annu Rev. Immunol., 12: 181-207, 1994.